Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
The European Heart Journal – Cardiovascular Pharmacotherapy (EHJ-CVP) is the official journal of the European Society of Cardiology and the ESC Working Group on Cardiovascular Pharmacotherapy. The journal reports on the interpretation and integration of new scientific developments to improve the pharmacological treatment of patients with cardiovascular disease.
It publishes original articles on clinical research, with new and established drugs and methods, as well as meta-analysis and topical reviews.
ESC Professional and Professional Plus Members can receive the journal for €73.
Working Group on Cardiovascular Pharmacotherapy Members can receive the journal for €103.80.
Become a member
Receive the table of contents in your mailbox.
Track topics and authors important to you and receive articles in your mailbox.
Before being published, all manuscripts go through double-blind, peer review by experienced international experts.
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.